Abstract
Bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) USA600 has been associated with increased patient mortality. We found that USA600 MRSA exhibited significantly increased resistance to human cathelicidin LL-37 killing and daptomycin MIC creep compared to non-USA600 MRSA. Virulent health care-associated MRSA strains may coevolve innate host defense peptide and antibiotic resistances.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Antimicrobial Cationic Peptides / pharmacology*
-
Bacteremia / microbiology
-
Bacteremia / mortality
-
Cathelicidins
-
Cross Infection / microbiology
-
Cross Infection / mortality*
-
Daptomycin / pharmacology*
-
Drug Resistance, Bacterial*
-
Hospitals
-
Humans
-
Methicillin-Resistant Staphylococcus aureus / drug effects*
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification
-
Microbial Sensitivity Tests
-
Microbial Viability / drug effects
-
Staphylococcal Infections / microbiology
-
Staphylococcal Infections / mortality*
-
United States
Substances
-
Anti-Bacterial Agents
-
Antimicrobial Cationic Peptides
-
Daptomycin
-
Cathelicidins